Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Doxorubicin Hydrochloride for Injection

Approval Number

国药准字H20013334

Company辉瑞制药（无锡）有限公司

Registration Date

August 13, 2020

Drug Information

Generic Name

注射用盐酸多柔比星

Dosage Form

注射剂

Strength

10mg(按C27H29NO11.HCL计算)

Drug Type

化学药品

Registration Date

August 13, 2020

Company Information

Applicant Company

Company Name辉瑞制药（无锡）有限公司

Manufacturing Company

Company Name辉瑞制药（无锡）有限公司

Company Address

江苏省无锡市滨湖区马山7号桥

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy